• Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine Cite CITE Title : Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine Personal Author(s) : Wallace, Megan Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114159 Wallace, Megan (2022). Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine. 202203(16). Wallace, Megan "Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine" 202203, no. 16 (2022) Wallace, Megan "Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine" vol. 202203, no. 16, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 580.91 KB] Personal Author: Wallace, Megan February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 06-COVID-Wallace-508.pdf File Type: [PDF - 580.91 KB] File Type: [PDF - 580.91 KB] Canadian experience and evidence with COVID-19 vaccine primary series extended intervals Cite CITE Title : Canadian experience and evidence with COVID-19 vaccine primary series extended intervals Personal Author(s) : Tunis, Matthew;Warshawsky, Byrna;Ogunnaike-Cooke, Susann; Corporate Authors(s) : Public Health Agency of Canada. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114162 Tunis, Matthew et al. (2022). Canadian experience and evidence with COVID-19 vaccine primary series extended intervals. 202203(19). Tunis, Matthew and Warshawsky, Byrna and Ogunnaike-Cooke, Susann "Canadian experience and evidence with COVID-19 vaccine primary series extended intervals" 202203, no. 19 (2022) Tunis, Matthew et al. "Canadian experience and evidence with COVID-19 vaccine primary series extended intervals" vol. 202203, no. 19, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 897.54 KB] Personal Author: Tunis, Matthew ; Warshawsky, Byrna ... February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 09-COVID-Tunis-508.pdf File Type: [PDF - 897.54 KB] File Type: [PDF - 897.54 KB] Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age Cite CITE Title : Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age Personal Author(s) : Das, Rituparna Corporate Authors(s) : Moderna (firm) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114155 Das, Rituparna (2022). Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age. 202203(12). Das, Rituparna "Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age" 202203, no. 12 (2022) Das, Rituparna "Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age" vol. 202203, no. 12, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 791.03 KB] Personal Author: Das, Rituparna February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 02-COVID-Das-508.pdf File Type: [PDF - 791.03 KB] File Type: [PDF - 791.03 KB] Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change Cite CITE Title : Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change Personal Author(s) : Kracalik, Ian Corporate Authors(s) : CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114157 Kracalik, Ian (2022). Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change. 202203(14). Kracalik, Ian "Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change" 202203, no. 14 (2022) Kracalik, Ian "Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change" vol. 202203, no. 14, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.10 MB] Personal Author: Kracalik, Ian February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 04-COVID-Kracalic-508.pdf File Type: [PDF - 1.10 MB] File Type: [PDF - 1.10 MB] Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax Cite CITE Title : Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114160 Oliver, Sara E. (2022). Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax. 202203(17). Oliver, Sara E. "Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax" 202203, no. 17 (2022) Oliver, Sara E. "Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax" vol. 202203, no. 17, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 6.00 MB] Personal Author: Oliver, Sara E. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 07-COVID-Oliver-508.pdf File Type: [PDF - 6.00 MB] File Type: [PDF - 6.00 MB] Myocarditis and COVID-19 vaccine intervals : international data and policies Cite CITE Title : Myocarditis and COVID-19 vaccine intervals : international data and policies Personal Author(s) : Moulia, Danielle Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114164 Moulia, Danielle (2022). Myocarditis and COVID-19 vaccine intervals : international data and policies. 202203(11). Moulia, Danielle "Myocarditis and COVID-19 vaccine intervals : international data and policies" 202203, no. 11 (2022) Moulia, Danielle "Myocarditis and COVID-19 vaccine intervals : international data and policies" vol. 202203, no. 11, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 548.99 KB] Personal Author: Moulia, Danielle February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 11-COVID-Moulia-508.pdf File Type: [PDF - 548.99 KB] File Type: [PDF - 548.99 KB] Updates to interim clinical considerations for use of COVID19 vaccines Cite CITE Title : Updates to interim clinical considerations for use of COVID19 vaccines Personal Author(s) : Hall, Elisha Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114161 Hall, Elisha (2022). Updates to interim clinical considerations for use of COVID19 vaccines. 202203(18). Hall, Elisha "Updates to interim clinical considerations for use of COVID19 vaccines" 202203, no. 18 (2022) Hall, Elisha "Updates to interim clinical considerations for use of COVID19 vaccines" vol. 202203, no. 18, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.41 MB] Personal Author: Hall, Elisha February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 08-COVID-Hall-508.pdf File Type: [PDF - 1.41 MB] File Type: [PDF - 1.41 MB] Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination Cite CITE Title : Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114156 Shimabukuro, Tom T. (2022). Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination. 202203(13). Shimabukuro, Tom T. "Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination" 202203, no. 13 (2022) Shimabukuro, Tom T. "Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination" vol. 202203, no. 13, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 756.09 KB] Personal Author: Shimabukuro, Tom T. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 03-COVID-Shimabukuro-508.pdf File Type: [PDF - 756.09 KB] File Type: [PDF - 756.09 KB] Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines Cite CITE Title : Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114165 Oliver, Sara E. (2022). Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines. 202203(12). Oliver, Sara E. "Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines" 202203, no. 12 (2022) Oliver, Sara E. "Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines" vol. 202203, no. 12, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.50 MB] Personal Author: Oliver, Sara E. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 12-COVID-Oliver-508.pdf File Type: [PDF - 1.50 MB] File Type: [PDF - 1.50 MB] ACIP COVID-19 Vaccines Work Group Cite CITE Title : ACIP COVID-19 Vaccines Work Group Personal Author(s) : Daley, Matthew F. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114154 Daley, Matthew F. (2022). ACIP COVID-19 Vaccines Work Group. 202203(11). Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group" 202203, no. 11 (2022) Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group" vol. 202203, no. 11, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.03 MB] Personal Author: Daley, Matthew F. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 01-COVID-Daley-508.pdf File Type: [PDF - 1.03 MB] File Type: [PDF - 1.03 MB] COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment Cite CITE Title : COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment Personal Author(s) : Talbot, H. Keipp;Hopkins, Robert H.; Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. COVID-19 Vaccine Safety Technical (VaST) Subgroup. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114158 Talbot, H. Keipp and Hopkins, Robert H. (2022). COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment. 202203(15). Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment" 202203, no. 15 (2022) Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment" vol. 202203, no. 15, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 306.66 KB] Personal Author: Talbot, H. Keipp ; Hopkins, Robert H. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 05-COVID-Talbot-508.pdf File Type: [PDF - 306.66 KB] File Type: [PDF - 306.66 KB]

More +